Guiyang Xintian Pharmaceutical Co.,Ltd.

¥7.55As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002873Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (5.84%)
Div yield 0.40%
ROE 0.75%
Biotechnology
Beta (5Y) 0.12
PE TTM 179.9
TSR TTM (30.25%)
Mkt cap ¥1.795B
ROIC 1.14%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.78
3.11%
(96.43%)
Hold 12|0|1|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.19
0.21
0.23
16.54%
18.25%
29.38%
39.16%
Revenue¥M
83.59
84.84
83.70
82.53
8.73%
6.73%
5.32%
4.16%
Peers (US$269.1M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
6.453
(0.349)
(0.253)
EBIT/Intx
1.142
2.672
2.098
Own earn%
16.08
80.57
95.23
Sh yield%
44.36
43.36
36.88
Owners
Insiders/Inst%
13.53
71.67
Short interest%
1.38
SBC / revenue%
3.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
4